Avobenzone; Ecamsule; Octocrylene Patent Expiration

Avobenzone; Ecamsule; Octocrylene is Used for protecting the skin from harmful UV rays and reducing the risk of sunburn and skin damage. It was first introduced by Loreal Usa Products Inc in its drug Anthelios Sx on Jul 21, 2006. Another drug containing Avobenzone; Ecamsule; Octocrylene is Capital Soleil 15.


Avobenzone; Ecamsule; Octocrylene Patents

Given below is the list of patents protecting Avobenzone; Ecamsule; Octocrylene, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Anthelios Sx US5587150 Photostable cosmetic screening composition containing a UV-A screening agent and an alkyl β, β-diphenylacrylate or α-cyano-β,β-diphenylacrylate Dec 24, 2013

(Expired)

Loreal Usa



Avobenzone; Ecamsule; Octocrylene's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List